Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatuline Autogel 90 mg in Dumping Syndrome
2008-000643-34Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Mar 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dumping syndrome comparing Somatuline Autogel 90 mg with Placebo (2 arms). Primary endpoint: Efficacy on dumping syndrome (Treatment Assessment Scale and dumping score). Started Mar 2008; status: completed.
02
Drugs
lanreotide
03
Conditions
dumping syndrome
Beyond the preview
Go deeper on 2008-000643-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000643-34.